Sleepiness during the night shift, postintervention; · patients with sleep disturbances caused by shift work
1 finding from 1 review
Sleepiness during the night shift, postintervention; · patients with sleepiness caused by shift work
1 finding from 1 review
Sleep latency MSLT. Scale from: 0 to 20 minutes. · patients with sleepiness caused by shift work
1 finding from 1 review
Sleepiness during the night shift, postintervention; · patients with sleepiness caused by shift work
1 finding from 1 review
Sleep latency MSLT. Scale from: 0 to 20 minutes. · patients with sleepiness caused by shift work
1 finding from 1 review
Severity/intensity of MUPS (post‐treatment score on self report scales) Different self report and clinician‐rated scales (SOMS‐7, SCL‐90 Somatisation Score) · somatoform disorders in adults
1 finding from 1 review
Anxiety · somatoform disorders in adults
1 finding from 1 review
Endpoint score (HDRS or MADRS) · somatoform disorders in adults
1 finding from 1 review
Withdrawals due to adverse events · somatoform disorders in adults
New‐generation antidepressants showed no clear difference in adverse effects (drop‐outs due to adverse effects) compared with placebo (low certainty).
1 finding from 1 review
Treatment response (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults
It is very uncertain whether new‐generation antidepressants changes treatment response (post‐treatment score on self report and… compared with placebo (very low certainty).
1 finding from 1 review
Quality of life at post‐treatment Indexed by self‐report measures of quality of life or functional disability · somatoform disorders in adults
1 finding from 1 review
Severity/intensity of MUPS (post‐treatment score on self report scales) Different self report and clinician‐rated scales (SOMS‐7, SCL‐90 Somatisation Score) · somatoform disorders in adults
1 finding from 1 review
Acceptability · somatoform disorders in adults
Natural products showed no clear difference in acceptability (all‐cause drop‐outs4) compared with placebo (low certainty).
1 finding from 1 review
Anxiety · somatoform disorders in adults
1 finding from 1 review
Depression (post‐treatment score on self report and clinician‐rated scales) Different self report and clinician‐rated scales (HDRS, BDI) · somatoform disorders in adults
1 finding from 1 review
Adverse effects (drop‐outs due to adverse effects4) · somatoform disorders in adults
Natural products showed no clear difference in adverse effects (drop‐outs due to adverse effects4) compared with placebo (low certainty).
1 finding from 1 review
Acceptability · somatoform disorders in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment response (post‐treatment score on self report and clinician‐rated scales) · somatoform disorders in adults
It is very uncertain whether natural products changes treatment response (post‐treatment score on self report and… compared with placebo (very low certainty).
1 finding from 1 review
Quality of life at post‐treatment Indexed by self‐report measures of quality of life or functional disability · somatoform disorders in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severity/intensity of MUPS (post‐treatment score on self report scales) Different self report scales (VAS‐Pain, SCL‐90‐R Somatisation Subscore) · somatoform disorders in adults
1 finding from 1 review